Global burden of anticancer drug-induced acute kidney injury and tubulointerstitial nephritis from 1...
Global burden of anticancer drug-induced acute kidney injury and tubulointerstitial nephritis from 1967 to 2023
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
This study aims to figure out the worldwide prevalence of anticancer therapy-associated acute kidney injury (AKI) and tubulointerstitial nephritis (TIN) and the relative risk of each cancer drug. We conducted an analysis of VigiBase, the World Health Organization pharmacovigilance database, 1967–2023 via disproportionate Bayesian reporting method....
Alternative Titles
Full title
Global burden of anticancer drug-induced acute kidney injury and tubulointerstitial nephritis from 1967 to 2023
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_ba9d92237d2c41999dfb330a907cf7e9
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ba9d92237d2c41999dfb330a907cf7e9
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-024-67020-x
